ARAX Capital Partners

What is ARAX Capital Partners?

ARAX Capital Partners is a venture capital firm founded in 2007 with a focus on financing growth companies in Austria, specializing in the high-tech and biotechnology sectors. They aim to finance Austrian technology and life science companies, with an emphasis on investments in pharmaceuticals, healthcare, and biotechnology industries. ARAX is one of the leading venture capital providers in Austria, with activities spanning across various asset classes including private equity, venture capital, and real estate.

Through their VE Immo GmbH, ARAX also handles the acquisition, planning, construction, renovation, and mediation of real estate, providing investors with an attractive opportunity for portfolio diversification. The firm supports funded companies not just in development but also accompanies them to the capital market through IPOs or alternative realization opportunities to achieve their full potential value.

ARAX believes that a combination of quality and diverse experience backgrounds of their management team is essential for success.

The team is characterized by first-class industry expertise and complementary skills from a multi-disciplinary team.

ARAX Capital Partners manages a current (prospective) portfolio, which includes innovative companies such as finsago, offering AI-based price models for insurance meta-search; greenpass, providing climate-resilient real estate solutions; and brainhero, developing personalized neurotherapy innovations.

The firm maintains a substantial under management portfolio, a track record of financed companies, exits, and has supported IPOs, indicating their significant role in the Austrian venture ecosystem.

They finance domestic growth companies from high tech and biotech sectors allowing investors to become co-entrepreneurs and benefit from the growth of local enterprises. ARAX's service partner, BVT Beteiligungsverwaltung und Treuhand GmbH, ensures all associated tasks related to investors' commitments are conducted efficiently, transparently, and tailored to personal situations, goals, and requirements.

What they say:

We provide early stage investments to Austrian startups.

What we look for: We invest in biotechnology and artificial intelligence.